Purple Biotech (PPBT) Competitors $2.49 +0.09 (+3.92%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$2.41 -0.08 (-3.33%) As of 07/3/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PPBT vs. MTVA, TRIB, ATHA, BGXX, BCDA, EQ, SNSE, LPTX, BTAI, and XFORShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include MetaVia (MTVA), Trinity Biotech (TRIB), Athira Pharma (ATHA), Bright Green (BGXX), BioCardia (BCDA), Equillium (EQ), Sensei Biotherapeutics (SNSE), Leap Therapeutics (LPTX), BioXcel Therapeutics (BTAI), and X4 Pharmaceuticals (XFOR). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. Its Competitors MetaVia Trinity Biotech Athira Pharma Bright Green BioCardia Equillium Sensei Biotherapeutics Leap Therapeutics BioXcel Therapeutics X4 Pharmaceuticals MetaVia (NASDAQ:MTVA) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment. Do institutionals and insiders have more ownership in MTVA or PPBT? 1.4% of MetaVia shares are held by institutional investors. Comparatively, 9.6% of Purple Biotech shares are held by institutional investors. 0.8% of MetaVia shares are held by insiders. Comparatively, 3.0% of Purple Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings and valuation, MTVA or PPBT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMetaViaN/AN/A-$27.59MN/AN/APurple BiotechN/AN/A-$7.24M-$2.62-0.95 Is MTVA or PPBT more profitable? Purple Biotech's return on equity of -17.84% beat MetaVia's return on equity.Company Net Margins Return on Equity Return on Assets MetaViaN/A -222.13% -123.85% Purple Biotech N/A -17.84%-15.44% Does the media favor MTVA or PPBT? In the previous week, MetaVia had 1 more articles in the media than Purple Biotech. MarketBeat recorded 1 mentions for MetaVia and 0 mentions for Purple Biotech. MetaVia's average media sentiment score of 0.00 equaled Purple Biotech'saverage media sentiment score. Company Overall Sentiment MetaVia Neutral Purple Biotech Neutral Do analysts recommend MTVA or PPBT? MetaVia currently has a consensus price target of $7.50, suggesting a potential upside of 1,057.59%. Purple Biotech has a consensus price target of $33.00, suggesting a potential upside of 1,223.18%. Given Purple Biotech's higher probable upside, analysts plainly believe Purple Biotech is more favorable than MetaVia.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MetaVia 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Purple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, MTVA or PPBT? MetaVia has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. SummaryPurple Biotech beats MetaVia on 7 of the 9 factors compared between the two stocks. Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PPBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.19M$2.91B$5.53B$8.95BDividend YieldN/A2.42%5.38%4.09%P/E Ratio-0.9521.5627.4020.24Price / SalesN/A277.33417.66125.07Price / CashN/A41.9536.6357.47Price / Book0.107.518.085.67Net Income-$7.24M-$55.05M$3.16B$248.47M7 Day Performance5.28%4.59%2.81%3.29%1 Month Performance-7.63%4.86%3.69%5.18%1 Year PerformanceN/A5.82%35.30%21.35% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech2.4445 of 5 stars$2.49+3.9%$33.00+1,223.2%N/A$3.19MN/A-0.9520Gap UpMTVAMetaVia1.5483 of 5 stars$0.64+2.1%$7.50+1,066.0%N/A$12.34MN/A0.008Gap DownTRIBTrinity Biotech0.4147 of 5 stars$0.65-0.3%N/A-65.6%$11.77M$61.56M-0.23480Gap UpATHAAthira Pharma2.9161 of 5 stars$0.30+2.4%$11.25+3,625.2%-87.1%$11.52MN/A-0.1540Gap DownBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownBCDABioCardia4.0073 of 5 stars$1.95-9.3%$25.00+1,182.1%-29.4%$11.13M$60K-0.8440News CoveragePositive NewsInsider TradeGap UpEQEquillium1.8557 of 5 stars$0.32+1.7%$3.00+851.8%-50.6%$11.07M$41.10M-0.8140Gap UpSNSESensei Biotherapeutics4.2241 of 5 stars$8.58-1.2%$90.00+949.0%-27.1%$10.94MN/A-0.3740Gap DownLPTXLeap Therapeutics1.4503 of 5 stars$0.30+13.5%$3.38+1,036.7%-84.3%$10.84MN/A-0.1740BTAIBioXcel Therapeutics4.3275 of 5 stars$1.81+2.3%$42.60+2,253.6%-88.7%$10.72M$2.27M-0.1390Gap UpXFORX4 Pharmaceuticals4.7256 of 5 stars$1.90+3.8%$72.33+3,707.0%-88.4%$10.59M$2.56M0.8980News CoverageHigh Trading Volume Related Companies and Tools Related Companies MetaVia Competitors Trinity Biotech Competitors Athira Pharma Competitors Bright Green Competitors BioCardia Competitors Equillium Competitors Sensei Biotherapeutics Competitors Leap Therapeutics Competitors BioXcel Therapeutics Competitors X4 Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PPBT) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPBT Stock Alerts